Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 0.63 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.54 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2418955 | 1.00 | TRPA1 (0.63) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL16702847 | 0.89 | TRPA1 (0.68) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL11235771 | 0.87 | TRPA1 (0.50) | TRPA1ALDH1A1 | |
| SCHEMBL13335229 | 0.86 | TRPA1 (0.63) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL7562754 | 0.86 | TRPA1 (0.63) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL3672929 | 0.85 | TRPA1 (0.67) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL16685763 | 0.84 | TRPA1 (0.61) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL15093734 | 0.84 | TRPA1 (0.61) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL11035088 | 0.84 | TRPA1 (0.61) | TRPA1TAAR1AOC3LMNARIPK1 | |
| SCHEMBL108142 | 0.83 | CYP2C9 (0.50) | TRPA1LMNAKDM4EADRA2AADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1900800-A2 | 4-phenyl-pentan-2-ol as odorous and aromatic substance | Symrise GmbH & Co. KG (DE) | 2008-03-19 | — | — | EP | disclosed |
| US-20080064625-A1 | 4-Phenylpentan-2-ol as a fragrance and flavouring | SYMRISE GMBH & CO. KG (DE) | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064625-A1 | 4-Phenylpentan-2-ol as a fragrance and flavouring | PNN, P4HA1, DPM1 | TRPA1 11/4885TAAR1 660/4885AOC3 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.